Dipeptidyl peptidase-4 inhibitor, vildagliptin, improves trabecular bone mineral density and microstructure in obese, insulin-resistant, pre-diabetic rats
With federal routes closing, pharmaceutical companies focused on shaping public opinion and state-level regulations
Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration
GLP-1 drugs may also cause other side effects, among them nausea, gastrointestinal issues and fatigue
To meet the needs of customers from both inland and abroad, we have set up warehouses in Tianjin, Shanghai, and Guangzhou
Some of the early once-weekly therapies for GLP-1s for treating diabesity were based on an antibody fragment that was only available in an autoinjector, explains Ian Thompson, Vice President Account & Business Development, Ypsomed